Paclitaxel and Carboplatin Combination Chemotherapy in a Hemodialysis Patient with Advanced Ovarian Cancer

2002 ◽  
Vol 84 (2) ◽  
pp. 335-338 ◽  
Author(s):  
Minoru Watanabe ◽  
Yoichi Aoki ◽  
Masatoshi Tomita ◽  
Takaaki Sato ◽  
Yoshihiro Takaki ◽  
...  
Cancer ◽  
1987 ◽  
Vol 60 (9) ◽  
pp. 2150-2155 ◽  
Author(s):  
Thomas W. Griffin ◽  
Richard A. Hunter ◽  
Andrew I. Cederbaum ◽  
Won K. Tak ◽  
Allen D. Ward ◽  
...  

2007 ◽  
Vol 17 (5) ◽  
pp. 1140-1143 ◽  
Author(s):  
M Modares Gilani ◽  
M Karimi Zarchi ◽  
N. Behtash ◽  
F. Ghaemmaghami ◽  
A. S. Mousavi ◽  
...  

To report a case of FIGO stage III papillary serous carcinoma of ovary, diagnosed during pregnancy at 20 weeks of gestation and treated with unilateral salpingo-oophorectomy and surgical staging, then initial combination chemotherapy while preserving the pregnancy. The patient underwent cesarean section at 35 weeks after four courses of taxol plus carboplatin. She delivered a healthy baby. After that total hysterectomy, omentectomy, pelvic and para-aortic lymphadenectomies were carried out. The surgical resection was complete and no macroscopic residual diseases were seen. During histologic examination, traces of resistant disease were found. The patient underwent three postoperative courses of chemotherapy (carboplatin plus paclitaxel regimen). After 6 months follow-up, the patient remained in complete remission and the child's development was normal. Combination chemotherapy during pregnancy with preservation of the fetus could be considered, and should be discussed with caution in case of epithelial ovarian cancer diagnosed during the second trimester of the pregnancy.


1989 ◽  
Vol 60 (5) ◽  
pp. 755-758 ◽  
Author(s):  
AE Athanassiou ◽  
D Bafaloukos ◽  
D Pectasides ◽  
M Dimitriadis ◽  
I Varthalitis ◽  
...  

2006 ◽  
Vol 16 (Suppl 1) ◽  
pp. 391-393 ◽  
Author(s):  
G. Ostoros ◽  
A. Pretz ◽  
J. Fillinger ◽  
I. Soltesz ◽  
B. Dome

Fatal lung fibrosis caused by paclitaxel toxicity has not been reported In this report, we describe the case of a 62-year-old woman who received six cycles of paclitaxel and carboplatin as combination chemotherapy for advanced ovarian cancer. Four weeks after the end of the chemotherapy she developed interstitial pneumonitis and irreversible lung fibrosis. Despite treatment with corticosteroids, she had rapid deterioration and died of respiratory failure. Pulmonary fibrosis is a complication of paclitaxel therapy that may occur despite treatments with corticosteroids. While reviewing the literature, we found few less severe pulmonary injuries after intravenous use of paclitaxel, but none of these cases had a fatal outcome. Physicians should keep in mind that taxanes such as paclitaxel have the potential to cause pneumonitis and lung fibrosis.


1985 ◽  
Vol 20 (3) ◽  
pp. 290-297 ◽  
Author(s):  
P.F. Conte ◽  
M.R. Sertoli ◽  
M. Bruzzone ◽  
A. Rubagotti ◽  
R. Rosso ◽  
...  

1980 ◽  
Vol 132 (2) ◽  
pp. 225-229 ◽  
Author(s):  
AKIRA YAJIMA ◽  
HISASHI HIGASHIIWAI ◽  
AKIRA SATO ◽  
MASAAKI WATANABE ◽  
TOSHIHIKO MORI ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document